NIA invites ideas on how to increase enrollment in Alzheimer’s clinical trials

The National Institute on Aging, a component of the National Institutes of Health, is seeking ideas for increasing enrollment in clinical trials and studies that address Alzheimer’s disease and related conditions. As described in the Request for Information (NOT-AG-12-017), input is invited on the following topics:

  • “Please describe strategies that should be more widely adopted to enhance participation in Alzheimer’s research among people at different stages of the disease (including pre-clinical), normal controls, those with a family history, racial and ethnic minorities, and others. Please indicate what support and coordination may be needed in the short-term and long-term for these efforts. 

  • “Please indicate the most effective role for government agencies and funders (federal, state, and local) to support and facilitate coordination of Alzheimer’s clinical trial recruitment efforts. 

  • “Please describe how registries can be used to support Alzheimer’s and related clinical trials and studies. Please discuss whether there is a need for a centralized registry and how existing registries and tools might be coordinated and used most effectively.”

This solicitation is part of the implementation of the National Plan to Address Alzheimer’s Disease (see previous coverage).

The deadline for comments is March 15, 2013. Additional information can be found in the Request for Information.